Loading…
Place of performance
Washington, District of Columbia
Response deadline
Jul 30, 2026, 09:00 PM
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Read the full solicitation
Start free to unlock the complete notice, the contracting officer’s contact details, and every solicitation document.
Erin Greninger, Contracting Officer
Activity in our index
7 opportunities · avg award $340.9M (1) · last active Sep 30, 2026.
Greg Smith
Activity in our index
6 opportunities · avg award $340.9M (1) · last active Sep 30, 2026.
Draft an outreach email with AI
A tailored, professional email to the contracting officer about this solicitation — written in seconds, grounded in this notice.
Free with an account · included with a WinAContract account. AI-written, grounded in this notice — review before sending.
2 solicitation documents on this notice
Start free to download the full solicitation package — statement of work, attachments and amendments.
Send it to GovCon — docs + AI brief, automatically.
We pull the solicitation files and summarize what you need to know (2 documents on this notice).
